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Objective: To explore anti-inﬂammatory activities of organic extract and its semi-
puriﬁed fractions (ethanol, acetone, methanol/dichloromethane) from the Mediterranean
gorgonian Eunicella singularis.
Methods: The anti-inﬂammatory and analgesic activities were evaluated, using the
carrageenan-induced rat paw edema model and the acetic acid writhing test in mice. The
gastroprotective activity was determined using HCl/EtOH induced gastric ulcers in rats.
The puriﬁcation and structure elucidation of compound(s) from the more effective frac-
tion were determined by chromatographic and spectroscopic methods and in comparison
with data reported in the literature.
Results: The fraction F–EtOH showed an important anti-inﬂammatory activity associ-
ated with signiﬁcant analgesic and gastroprotective properties. The puriﬁcation and
structure elucidation of compound(s) from this fraction lead to the identiﬁcation of one
diterpenoid and four sterols.
Conclusions: These results suggested that components from the active fraction can be
used to treat various anti-inﬂammatory diseases.1. Introduction
Inﬂammation is a protective response to tissue injury caused
by physical trauma, noxious stimuli by chemical agents, heat,
antigen–antibody reaction and microbial effect. The signs and
symptoms of inﬂammation, which sometimes may be potentially
harmful needs pharmacological treatment [1]. Currently, non-
steroidal anti-inﬂammatory drugs are used throughout the
world for the treatment of inﬂammation, pain and fever; how-
ever most of these produce several adverse reactions such as
ulcers and hemorrhage [2]. The side effects of non-steroidal anti-inﬂammatory drugs may be associated to the inhibition of
cyclooxygenase (COX)-1, enzyme involved in the synthesis of
prostaglandins vital to normal cell function besides the inhibition
of the COX-2 produced in response to growth factors or in-
ﬂammatory mediators [3]. In addition to non-steroidal anti-in-
ﬂammatory drugs, multiple factors including stress, smoking,
nutritional deﬁciencies, noxious agents such as alcohol, and
Helicobacter pylori infection caused gastric ulcer [4]. Actually,
drugs used for the treatment of gastric ulcer including
histamine H2-antagonists, proton pump inhibitors, and anti-
muscarinics, as well as acid-independent therapy provided by
sucralfate [5], induce adverse generate side effects such as
hypersensitivity, arrhythmia, impotence, and hematopoietic
changes. Therefore, the development of potent anti-ulcer and
anti-inﬂammatory drugs from natural sources and with fewer
side effects is necessary. In recent years, the soft corals and
gorgonians of Octocorallia have become a new marine resourceopen access article under the CC BY-NC-ND
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pounds in drug development [6]. The family Gorgoniidae has
been demonstrated to contain a wide variety of natural
products including steroids, acetogenins, sesquiterpenes and
diterpenes [7]. Among the substances that currently receive the
most attention for drug design include the diterpenes puriﬁed
from gorgonian, possessing a variety of pharmacologic effects,
including anticancer, gastroprotective and anti-inﬂammatory
properties [8]. Despite the biodiversity of the Mediterranean
Tunisian coast, minimal efforts on the chemistry and
biological activities of marine organisms have been conducted.
Therefore, in a program to ﬁnd new natural sources of anti-
inﬂammatory agents with gastroprotective effect from Tunisian
marine invertebrates, we studied the efﬁciency of organic extract
and its fractions from the white gorgonian Eunicella singularis
(E. singularis) (Cnidaria: Octocorallia, Esper 1791). The struc-
ture elucidation of the isolated compounds from the active
fraction was done by 1D and 2D NMR experiments and by
comparison with literature data.
2. Materials and methods
2.1. Collection and extraction
E. singularis was collected from the Mediterranean Sea in
various areas of the coastal region of Tabarka (Tunisia), in June
2010, at a depth between 20 and 30 m. Identiﬁcation of speci-
mens was carried out in the National Institute of Marine Sci-
ences and Technologies (Salamboo, Tunisia). After maceration
of the powdered material with methanol and dichloromethane
(1:1, v/v) for 48 h three times, the organic extract was puriﬁed,
using C18 cartridges (Sep-pack, Supelco), by gradient elution
with different organic solvents in the order of decreased polarity:
ethanol, acetone and methanol/CH2Cl2 (1:1) to give three semi-
puriﬁed fractions: ethanol (F–EtOH), acetone (F–Ac) and
methanol/CH2Cl2 (F–MeOH/CH2Cl2) fractions. Organic sol-
vents were removed from recuperated fractions using rotating
evaporator at 40 C.
2.2. Puriﬁcation, isolation and structure elucidation
F–EtOH was fractionated according to the Kupchan parti-
tioning procedure [9] as follow: the ethanolic fraction was
dissolved in a mixture of MeOH/H2O containing 10% H2O
and partitioned against n-hexane to give 10.3 g of the crude
extract. The water content (% v/v) of the MeOH extract was
adjusted to 30% and partitioned against CHCl3 to give 3.9 g
of the crude extract. The aqueous phase was concentrated to
remove MeOH and then extracted with n-BuOH (268 mg of
crude extract). The n-hexane extract (5 g) was fractioned by
silica gel MPLC using a solvent gradient system from CH2Cl2
to MeOH. Fraction eluted with CH2Cl2: MeOH 99:1 (307 mg)
was puriﬁed on a Nucleodur 100-5 C18 (5 m; 10 mm
i.d. × 250 mm) with 99% MeOH:H2O as eluent (ﬂow rate
3 mL/min) to give 2.2 mg of cholesta-5,22-dien-3b-ol (5)
(tR = 25.5 min).
Fraction eluted with CH2Cl2:MeOH 95:5 (42 mg) was puri-
ﬁed on a Nucleodur 100-5 C18 (5 m, 4.6 mm i.d. × 250 mm)
with 87% MeOH:H2O as eluent (ﬂow rate 1 mL/min) to give
0.8 mg of (22E)-cholesta-5,22-diene-3b,7a-diol (3)
(tR = 26.4 min), 0.6 mg of ergosta-5,24(28) diene-3b,7a-diol (4)(tR = 30 min) and 0.6 mg of cholest-5-ene-3b,7a-diol (2)
(tR = 33.6 min).
The CHCl3 extract (3.9 g) was chromatographed by silica gel
MPLC using a solvent gradient system from CH2Cl2 to CH2Cl2:
MeOH 1:1.
Fraction eluted with CH2Cl2: MeOH 95:5 (212 mg) was
further puriﬁed by HPLC on a Nucleodur 100-5 C18 (5 m,
4.6 mm i.d. × 250 mm) with 85% MeOH:H2O as eluent (ﬂow
rate 1 mL/min) to give 1.5 mg of palmonine F (1) (tR = 4.8 min).
NMR spectra were obtained on Varian Inova 400 and Varian
Inova 500 NMR spectrometers (1H at 400 and 500 MHz, 13C at
100 and 125 MHz, respectively) equipped with a Sun hardware,
d (ppm), J in hertz, and spectra referred to CD3Cl3 (dH = 7.27;
dC = 70.0) as internal standard. HPLC was performed using a
Waters model 510 pump equipped with Waters Rheodine
injector and a differential refractometer, model 401.
Medium pressure liquid chromatography was performed on a
Buchi apparatus using a silica gel (230–400 meshcolumn). The
purities of compounds were determined to be greater than 95%
by HPLC and NMR.
2.3. Pharmacological evaluation
2.3.1. Animals
Wistar rats of either sex, weighing 150–200 g, and swissal-
binos mice weighing 18–25 g of both sex were obtained from
Pasteur Institute (Tunis, Tunisia). Housing conditions and
in vivo experiments were approved according to the guidelines
established by the European Union on Animal Care (CCE
Council 86/609).
2.3.2. Carrageenan-induced rat paw edema
The anti-inﬂammatory activity of the organic extract and its
semi-puriﬁed fractions on carrageenan-induced paw edema was
determined according to Hossain et al. [1]. The animals were
divided into three groups of six rats each. The control group
received an intraperitoneal (ip.) dose of saline solution (NaCl
9‰, 2.5 mL/kg), the reference group received acetylsalicylate-
lysine (ASL) (300 mg/kg, ip.), and the test groups received
the organic extract of E. singularis (50, 100 and 200 mg/kg, ip.)
and its semi-puriﬁed fractions (25 and 50 mg/kg, ip.). After
30 min, 0.05 mL of a 1% carrageenan suspension was injected
into the left hind paw. The paw volume up to the tibiotarsal
articulation was measured using a plethysmometer (model 7150,
UgoBasile, Italy). The measures were determined at 0 h (V0)
(before carrageenan injection) and 1, 3 and 5 h later (VT) (after
carrageenan injection). Paw swelling was determined for each
rat and the difference between VT and V0 was taken as the
edema value. The percentages of inhibition were calculated ac-
cording to the following formula:
% inhibition = [(VT−V0) control−(VT−V0) treated group
/(VT−V0) control] × 100
2.3.3. Writhing assay in mice
The analgesic activity was performed according to the
method of Ayed et al. [10]. Swiss mice were divided into three
groups of six mice each. One group served as the control
group and was treated with 10 mL/kg of vehicle administered
through subcutaneous injection (s/c.). The second group was
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third group was treated with the organic extract of E. singularis
at different doses (100, 200 and 400 mg/kg, s/c), F–EtOH, F–Ac
and F–MeOH/CH2Cl2 fractions (25, 50 and 100 mg/kg, s/c).
30 min after the administration of these different substances,
all animals received 10 mL/kg (ip.) of 1% acetic acid. The
number of abdominal writhing as a pain indicator was counted
for 30 min.
2.3.4. Gastric lesions induced by HCl/ethanol
The gastroprotective activity of the organic fractions of
E. singularis was studied in 150 m MHCl/EtOH induced gastric
ulcer [4]. Rats were divided into three groups, fasted for 24 h
prior receiving an intraperitoneal doses of vehicle (NaCl 9‰,
2.5 mL/kg) for the control group, organic extract and fractions
(5, 10, 25, 50 and 100 mg/kg, ip.) for the test group.
Reference group, received cimetidine (100 mg/kg, ip.) and
omeprazole (30 mg/kg, ip.) as reference drugs. After 30 min,
all groups were orally treated with 1 mL/100 g of 150 m
MHCl/EtOH solution for gastric ulcer induction. Animals were
killed 1 h after the administration of ulcerogenicagent, their
stomachs were excised and opened along the great curvature,
washed and stretched on cork plates. The surface was
examined for the presence of lesions and the extent of the
lesions was measured. The summative length of the lesions
along the stomach was recorded (mm) as lesion index.
2.3.5. Statistical analysis
Data are presented as the mean ± standard error (SE). Sta-
tistical analysis was performed using Student's t-test. The sig-
niﬁcance of difference was considered to include values of
P < 0.05.
3. Results
As shown in Figure 1, 1D and 2D NMR analysis of the
ethanolic fraction (F–EtOH) from the gorgonian E. singularis
resulted in the identiﬁcation of ﬁve compounds.
Compound 1 was isolated as colorless oil. The molecular
formula was determined to be C24H38O6 by HRESIMS. The
analysis of 1H NMR spectrum clearly revealed aneunicell1 2
4
Figure 1. Chemical structures of ﬁve compounds isolated from the white gorg
One diterpenoid:palmonine F (1), and four sterols (2–5): cholest-5-ene-3b,7a-
3b,7a-diol (4); and cholesta-5, 22-diene-3b-ol (5).inditerpenoid structure. The 13C NMR spectrum revealed 24
carbon signals. 1H and 13C NMR assignments were carried out
with the aid of the detailed 2D analyses (COSY, HMQC,
NOESY, and HMBC) and the resulting NMR evidence revealed
1 to be deﬁned as palmonine F [11].
Compound 2 was isolated as colorless powder. The molec-
ular formula was determined to be C27H46O2. Analysis of
1H
and, 13C NMR data evidenced a D5dihydroxy-steroid structure
with a saturated C8 cholestane side chain. Comparison with
literature data allowed to assign the cholest-5-ene-3b,7a-diol
structure [12]. This compound was also isolated from the sponge
Stelodoryx chlorophylla [13], from a soft coral Dendronephthya
gigantea [14] and a marine bryozoan Biﬂustra grandicella [15].
Compound 3 has a molecular formula of C27H44O2 as
determined by HRESIMS. 1H and 13C NMR indicated that
compound 3 is the △22 derivative of compound 2.Therefore
compound 3 was identiﬁed as (22E) -cholesta-5,22-diene-3b,7a-
diol [12] (Figure 1).
Compound 4 was isolated as colorless powder. The molec-
ular formula was determined to be C28H46O2 and NMR analysis
indicated the presence of one exo-methylene function (dH 4.64,
br s and 4.78, br s). Its identity was determined by 1D and 2D
NMR data as ergosta-5,24(28) diene-3b,7a-diol earlier isolated
from the marine sponge Stelodoryx chlorophylla [13] and then
reported also from the soft coral Sinularia ﬂexibilis [16].
Compound 5 was isolated as colorless powder. The molec-
ular formula was determined to be C27H44O by HRESIMS data.
NMR data disclosed the cholesta-5,22-diene-3b-ol structure [17].
The anti-inﬂammatory activity of E. singularis organic
extract and its semi-puriﬁed fractions against acute pedal edema
(induced by carrageenan) is shown in Table 1 and the results are
comparable to that of the standard drug, ASL, a potent inhibitor
of cyclooxygenase-2. Carrageenan induced paw edema
remained even 6 h after its injection into the sub plantar region
of rat paw. ASL as a reference standard drug inhibited the edema
formation due to carrageenan to an extent of 52.78% (at 3 h) at
the dose of 300 mg/kg. The extract or fractions from
E. singularis signiﬁcantly inhibited edema formation in rats
(P < 0.01) in a dose dependent manner. The organic extract at
the dose of 200 mg/kg inhibited edema formation to the extent of
64.75% (at 3 h) and the edema was found to be reduced to3
5
onian E. singularis.
diol (2); (22E)-cholesta-5,22-diene-3b,7a-diol (3); ergosta-5,24(28) diene-
Figure 2. Effect of the organic extract (25, 50 and 100 mg/kg) and F–Ac (100 mg/kg) on gastric ulcer induced by HCl/ethanol in rats.
Table 2
Analgesic effect of the organic extract of E. singularis and its semi-
puriﬁed fractions in the acetic acid 1% writhing test in mice.
Treatment Dose
(mg/kg)
Number of writhes Inhibition of
writhing (%)
Vehicle – 86.00 ± 2.50 –
ASL 200 29.96 ± 2.40** 65.16
Organic extract 100 71.74 ± 1.60 16.57
200 51.22 ± 2.60 40.44
400 30.65 ± 2.30** 64.35
F–EtOH 25 71.38 ± 1.90 17.00
50 58.52 ± 3.70 31.95
100 32.56 ± 2.50** 62.13
F–Ac 25 77.22 ± 1.40 10.2
50 62.43 ± 2.30 27.4
100 37.53 ± 1.40** 56.36
F–MeOH/CH2Cl2 25 75.06 ± 4.60 12.71
50 59.41 ± 3.70 30.91
100 31.42 ± 4.90** 63.46
Values are expressed as mean ± SE. *P < 0.01, **P < 0.001. n = 6.
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at a dose of 50 mg/kg with a percentage of inhibition of edema
of 66.9% at 3 h, while F–Ac and F–MeOH/CH2Cl2 at a dose of
50 mg/kg reduced edema with a percentage of 49% and 54%,
respectively. The presence of edema is one of the prime signs of
inﬂammation [18]. Peripheral analgesic activity was assessed by
acetic-acid induced writhing test, which showed signiﬁcant
(P < 0.01) suppression of writhes (Table 2). Injection of acetic
acid into the control mice resulted in 86.0 ± 2.5 writhes. Pre-
treatment with organic extract at doses of 200 and 400 mg/kg
reduced the number of writhes to 51.22 (40.44% of inhibition)
and 30.65 (64.35% of inhibition) respectively. Interestingly, F–
MeOH/CH2Cl2 (31.42 writhes, 63.46% of inhibition) and F–
EtOH (32.56 writhes, 62% of inhibition) at a dose of 100 mg/kg
registered higher levels of analgesic activity than F–Ac (57.53
writhes, 56.36% of inhibition) and approaches the activity of the
standard drug ASL (29.96 writhes, 65% of inhibition).
The gastroprotective effect of E. singularis organic extract
and fractions against HCl/EtOH induced gastric damage in rats
is shown in (Figure 2–4) and the results are comparable to that of
the standard drugs cimetidine, a histamine H2 receptor antago-
nist, and omeprazole, a proton pump inhibitor [19]. For the
organic extract, the inhibition of gastric lesions varied between
46.7 and 68.8% at doses of 25 and 100 mg/kg (Figure 2). The
F–EtOH had the highest activity, the lesion index was inhibited
by 45%, 53%, 70%, 78% and 80% at doses of 5, 10, 25, 50 andTable 1
Anti-inﬂammatory effect of E. singularis organic extract and its semi-puriﬁe
Treatment Dose (mg/kg) Edema (10−2/m
1 h 3
Vehicle – 32.25 ± 2.38 54.75 ±
Organic extract 50 27.31 ± 3.55* 30.18 ±
100 21.16 ± 4.51* 21.76 ±
200 17.41 ± 2.13* 19.29 ±
F–EtOH 25 21.85 ± 3.50 43.30 ±
50 18.03 ± 1.80** 18.11 ±
F–Ac 25 23.06 ± 2.40* 48.33 ±
50 21.29 ± 2.50* 27.92 ±
F–MeOH/CH2Cl2 25 23.89 ± 1.90 39.63 ±
50 23.14 ± 2.70 24.91 ±
ASL 300 21.16 ± 2.25* 25.85 ±
Values are expressed as mean ± SEM; n = 6 animals.*P < 0.01, **P < 0.0
Vehicle: Ethanol: 5%; Tween 80: 5%; distilled water: 90%.100 mg/kg, respectively (Figure 3), While for the F–MeOH/
CH2Cl2, the inhibition of gastric lesions was observed only at
doses of 25, 50 and 100 mg/kg (Figure 4) which percentage was
65%, 68% and 73%, respectively. The F–Ac failed to reduce the
gastric lesions induced by EtOH/HCl.d fractions in carrageenan-induced rat paw edema test.
L) (mean ± SE) Edema inhibition (%)
h 5 h 1 h 3 h 5 h
3.30 55.50 ± 4.69 – – –
2.64** 32.01 ± 3.78** 15.31 44.87 42.31
5.74** 24.25 ± 3.86** 34.36 60.25 56.29
3.43** 20.92 ± 3.93** 45.99 64.75 62.30
2.40 49.92 ± 3.20 32.22 20.90 10.04
1.50** 19.77 ± 1.87** 44.08 66.92 64.37
3.80** 49.77 ± 1.50 28.49 11.71 10.31
4.40** 28.89 ± 2.78** 33.97 49.00 47.93
2.50 42.13 ± 3.20 25.92 27.61 24.09
3.10** 33.59 ± 3.30 28.22 54.49 39.47
2.31* 26.71 ± 2.25** 34.36 52.78 51.87
01.
Figure 3. Effect of F–EtOH (5–30 mg/kg) and reference drugs (cimetidine, 100 mg/kg; omeprazole, 30 mg/kg) on gastric ulcer induced by HCl/ethanol in
rats.
Figure 4. Effect of F–MeOH/CH2Cl2 (5–100 mg/kg) on gastric ulcer induced by HCl/ethanol in rats.
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The current study was carried out to determine the in vivo
anti-inﬂammatory, analgesic and gastroprotective activities of
the organic extract of E. singularis and its semi-puriﬁed frac-
tions. The chemical composition of the more effective fraction
was determined by both 1D and 2D NMR experiments.
Carrageenan induced edema has been commonly used as an
experimental animal model for acute inﬂammation and is believed
to be biphasic [20]. The early phase (1–2 h) of the carrageenan
model is mainly mediated by histamine, serotonin and increased
synthesis of prostaglandins in the damaged tissue surroundings.
The late phase (2.5–6 h) is due to the over production of
prostaglandin and nitric oxide with peak at 3 h, produced by
inducible isoform of cyclooxygenase (COX-2) and nitric oxide
synthase [21]. However, treatment with the organic extract or
fractions of E. singularis signiﬁcantly reduced, at dose
dependent manner, carrageenan on induced inﬂammation in
both phases (1–6 h) of the experiment. Based on this, it may be
that the organic extract/or fractions of E. singularis has a non-
selective inhibiting effect on the release or actions of these me-
diators of inﬂammation and the suppression of the 1st phase may
be due to inhibition of the release of early mediators, such as
histamine and serotonin and the action in the second phasemay be
explained by an inhibition of COX-2.
Peripheral analgesic activity was assessed by acetic-acid
induced writhing test. Acetic acid is known to trigger the pro-
duction of noxious substances within the peritoneum, whichinduces the writhing response [22]. The effect of organic extract
or fractions against the noxious stimulus may be an indication
that it depressed the production and release of mediators of
pain and there by bringing a reduction in the number of
writhes in animals. The writhing induced by chemical
substances is due to sensitization of nociceptors by
prostaglandins [23]. The results indicate that the analgesic
effect of the organic extract of E. singularis and its semi-
puriﬁed fractions might be mediated by its peripheral effects
by inhibiting the synthesis or action of prostaglandins.
Ethanol has been revealed to produce gastric damage and the
severity of gastric ulcer could be obviously evaluated by ulcer
lesions. In this study, results showed that ethanol/HCl alone
intake produced gastric mucosal damage, severe hemorrhage and
lesions ulcers. But, pretreatment by organic extract or fractions
from E. singularis effectively protected stomach tissues from
mucosal damage and gastric lesions ulcers. Moreover, the pro-
tective effect of this extract and fractions demonstrated a dose–
response relationship. Several mechanisms have been suggested
for the effect of gastroprotective compounds, including increase
in the gastric hexosamine level and enhancing the strength of the
gastric barrier either physically or by blocking the H+, K+/ATPase
pump [24]. Among the main classes of chemical bioactive
components capable of offering gastroprotection are triterpenes
[25]. The chemical analysis of the active fraction (F–EtOH)
revealed the presence of an eunicellin-type diterpenoid, palmo-
nine F (1) and four sterols: cholest-5-ene-3b,7a-diol (2); (22E)-
cholesta-5,22-diene-3b,7a-diol (3); ergosta-5,24(28) diene-
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penes or their derivatives have been shown to possess gastro-
protective activities in different models of induced gastric lesions
in animals [26]. In addition, Ioannou et al. [27] reported that
steroids of marine origin exhibited an anti-inﬂammatory activ-
ity. There is some study reporting the anti-inﬂammatory activity
of eunicellin-based diterpenoid [28]. This works seems to be
related with our results. On the other hand, anti-inﬂammatory,
analgesic and gastroprotective activities may be attributed to
various phenolic compounds (alkaloids, glycosides, terpenoids,
steroids, and saponins) detected in E. singularis organic extract
and fractions [29]. Several studies reported that alkaloids have
analgesic, anti-inﬂammatory and gastroprotective effects. Gly-
cosides, terpenoids and steroids detected in our samples are
known to have anti-inﬂammatory and analgesic properties [30].
The synergic effect of different compounds of E. singularis
ethanolic fraction may be responsible for its higher anti-
inﬂammatory and analgesic activities with gastroprotective effect.
In conclusion, the ethanolic fraction of E. singularis
demonstrated the highest activity in the three tests (anti-in-
ﬂammatory, analgesic and gastroprotective). The structure
elucidation of compounds isolated from this fraction revealed
the presence of a eunicellan-based diterpenoid and four sterols
which may be responsible for its activity.
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